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We study the discrete and discrete fractional representation of a pharmacokinetics - pharmacodynamics
(PK-PD) model describing tumor growth and anti-cancer effects in continuous time considering a time scale
hZ, where h > 0. Since the measurements of the tumor volume in mice were taken daily, we consider h = 1
and obtain the model in discrete time (i.e. daily). We then continue with fractionalizing the discrete nabla
operator to obtain the model as a system of nabla fractional difference equations. The nabla fractional
difference operator is considered in the sense of Riemann-Liouville definition of the fractional derivative. For
the data fitting purpose, we use a new developed method which is known as an improved version of the
partial sum method to estimate the parameters for discrete and discrete fractional models. Lastly, for the
purpose of practicality, we test the discrete models for their efficiency and illustrate their current limitations
for application.
